Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2010 Mar;17(1):33-42.
doi: 10.1007/s12529-009-9052-6.

Patient attitudinal and behavioral factors associated with warfarin non-adherence at outpatient anticoagulation clinics

Dean G Cruess  1 , A Russell Localio, Alec B Platt, Colleen M Brensinger, Jason D Christie, Robert Gross, Catherine S Parker, Maureen Price, Joshua P Metlay, Abigail Cohen, Craig W Newcomb, Brian L Strom, Stephen E Kimmel
Affiliations
Comparative Study

Patient attitudinal and behavioral factors associated with warfarin non-adherence at outpatient anticoagulation clinics

Dean G Cruess et al. Int J Behav Med. 2010 Mar.

Abstract

Background: Warfarin is an anticoagulant effective in preventing stroke, but it has a narrow therapeutic range requiring optimal adherence to achieve the most favorable effects.

Purpose: The goal of this study was to examine specific patient factors that might help explain warfarin non-adherence at outpatient anticoagulation clinics.

Method: In a prospective cohort study of 156 adults, we utilized logistic regression analyses to examine the relationship between the five Treatment Prognostics scales from the Millon Behavioral Medicine Diagnostic (MBMD), as well as three additional MBMD scales (Depression, Future Pessimism, and Social Isolation), and daily warfarin non-adherence assessed using electronic medication event monitoring systems caps over a median of 139 days.

Results: Four of the five Treatment Prognostic scales and greater social isolation were associated with warfarin non-adherence. When controlling for pertinent demographic and medical variables, the Information Discomfort scale remained significantly associated with warfarin non-adherence over time.

Conclusion: Although several factors were related to warfarin non-adherence, patients reporting a lack of receptivity to details regarding their medical illness seemed most at risk for warfarin non-adherence. This information might aid in the development of interventions to enhance warfarin adherence and perhaps reduce adverse medical events.

PubMed Disclaimer

References

    1. Hirsh J, Guyatt G, Albers GW, Schünemann HJ. The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy: evidence-based guidelines. Chest. 2004;126:172S–3S. - PubMed
    1. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation: analysis of pooled data from five randomized controlled trials. Arch Intern Med. 1994;154:1449–57. No authors listed. - PubMed
    1. The European Atrial Fibrillation Trial Study Group. Optimal oral anticoagulant therapy in patients with nonrheumatic atrial fibrillation and recent cerebral ischemia. N Engl J Med. 1995;333:5–10. - PubMed
    1. Samsa GP, Matchar DB, Goldstein LB, et al. Quality of anticoagulation management among patients with atrial fibrillation: results of a review of medical records from 2 communities. Arch Intern Med. 2000;160:967–73. - PubMed
    1. Wittkowsky AK, Devine EB. Frequency and causes of over-anticoagulation and underanticoagulation in patients treated with warfarin. Pharmacotherapy. 2004;24:1311–6. - PubMed

Publication types